National Coverage Analysis (NCA)

Tumor Antigen by Immunoassay CA 125 (Addition of Primary Peritoneal Adenocarcinoma as a Covered Indication)

CAG-00290R

Expand All | Collapse All

Documents

Contacts

Kimberly Long
kimberly.long@cms.hhs.gov
410-786-5702
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
First reconsideration Tumor Antigen by Immunoassay CA 125 (Addition of Primary Peritoneal Adenocarcinoma as a Covered Indication) CAG-00290R You are here